- Home
- KROS vs BLW Comparison
KROS vs BLW Comparison
Compare KROS & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | BLW |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 565.0M | 533.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | BLW |
|---|---|---|
| Price | $17.46 | $13.97 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $22.20 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 85.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.83% |
| EPS Growth | N/A | N/A |
| EPS | 1.57 | ★ 1.81 |
| Revenue | ★ $246,718,000.00 | N/A |
| Revenue This Year | $6,657.47 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.10 | ★ $7.73 |
| Revenue Growth | ★ 37798.31 | N/A |
| 52 Week Low | $9.12 | $12.35 |
| 52 Week High | $72.37 | $14.26 |
Technical Indicators
Market Signals| Indicator | KROS | BLW |
|---|---|---|
| Relative Strength Index (RSI) | 62.55 | 56.18 |
| Support Level | $16.63 | $13.64 |
| Resistance Level | $17.73 | $13.86 |
| Average True Range (ATR) | 0.78 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 55.71 | 65.22 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.